Curaleaf Expands Select Brand Products Into Connecticut.

Select Elite Live cartridges will be available at local medical dispensaries across the state.

Curaleaf Holdings, Inc. (CSE: CURA), a leading multi-state cannabis operator in the United States, today announced it will expand its line of Select brand products into Connecticut. Select Elite Live cartridges will be available at local medical dispensaries across the state.

We are committed to providing essential medicine to over 40,000 patients in Connecticut with consistent, high-quality Select products.Joe Bayern, President of Curaleaf

Select, which was acquired by Curaleaf in February 2020, is available in Oregon, California, Arizona and Nevada, and recently expanded to Colorado, Michigan, Maryland and Oklahoma. All Select products are formulated with strain-specific terpenes to enhance flavor. Curaleaf will expand its product line in the coming months across several states to include Select Elite Live cartridges, oil infused with freshly harvested live resin terpenes.

"We commend state lawmakers for adding chronic pain and Ehlers-Danlos Syndrome to its list of MMP qualifying conditions, and we look forward to providing quality medicine to current and future patients," said Joe Bayern, President of Curaleaf.

During the COVID-19 outbreak, cannabis businesses have been deemed an essential service in most states, including Connecticut. Curaleaf remains committed to serving patients with the products and service they rely on while implementing heightened safety and sanitation measures in all its facilities.

To learn more about Curaleaf Holdings, visit the company HQ here.